Intraarterial administration of emulsion formulations containing cyclandelate and nitroglycerin.
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D002415:Cats; D004305:Dose-Response Relationship, Drug; D004655:Emulsions / Q000008:administration & dosage; D006168:Guinea Pigs; D006614:Hindlimb / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D005996:Nitroglycerin / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D010477:Perfusion; D010919:Placebos; D011817:Rabbits; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity
D004655:Emulsions; D010919:Placebos; D014665:Vasodilator Agents; D005996:Nitroglycerin